Brand/Generic Settlement Opponents May Have To Settle For Less
Executive Summary
If it's Thursday, S. 369 must be on the agenda
You may also be interested in...
Brand/Generic Settlement Bill Advances; Will Debate Come Down To FTC v. CBO?
After clearing the Senate Judiciary Committee on Oct. 15, the next hurdle for legislation that would curtail settlement deals between brand firms and generic challengers may be obtaining a favorable score from the Congressional Budget Office
Brand/Generic Settlement Bill Advances; Will Debate Come Down To FTC v. CBO?
After clearing the Senate Judiciary Committee on Oct. 15, the next hurdle for legislation that would curtail settlement deals between brand firms and generic challengers may be obtaining a favorable score from the Congressional Budget Office
Teva Settlements Stick To Date of Entry Even As Legislative Debate Continues
Teva is taking a cautious approach in its patent settlements with brand firms - inking deals that meet the strict standards of pending legislation even as the bills are still under debate